Literature DB >> 7092006

Chronic granulomatous disease of childhood and Chromobacterium violaceum infections in the southeastern United States.

A M Macher, T B Casale, A S Fauci.   

Abstract

Patients with chronic granulomatous disease are predisposed to infections by catalase-positive organisms in the environment. Chromobacterium violaceum is a catalase-positive bacterium whose saprophytic source in this country is the subtropical soil and water of the southeastern United States. Two patients with chronic granulomatous disease, followed at the National Institutes of Health in Maryland, acquired C. violaceum infections in Florida. All 10 cases previously reported were acquired in Florida and Louisiana, and reports for which dates were available showed that all infections were acquired from June to September. Seven of 10 patients died; one patient was studied and found to have chronic granulomatous disease. Thus, at least three of the 12 known patients have had underlying chronic granulomatous disease. We suggest that C. violaceum infections occur with unusual frequency in patients with a common underlying predisposing disorder; C. violaceum poses a potential threat to patients with chronic granulomatous disease living in or visiting the endemic states.

Entities:  

Mesh:

Year:  1982        PMID: 7092006     DOI: 10.7326/0003-4819-97-1-51

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  18 in total

1.  Computational analysis suggests that virulence of Chromobacterium violaceum might be linked to biofilm formation and poly-NAG biosynthesis.

Authors:  Sidnei Becker; Cíntia Soares; Luismar Marques Porto
Journal:  Genet Mol Biol       Date:  2009-09-01       Impact factor: 1.771

2.  Chromobacterium violaceum infections in 13 non-human primates.

Authors:  David X Liu; Peter J Didier; Gail B Plauche
Journal:  J Med Primatol       Date:  2011-12-29       Impact factor: 0.667

3.  The Brief Case: Recurrent Chromobacterium violaceum Bloodstream Infection in a Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient Patient with a Severe Neutrophil Defect.

Authors:  Phyu M Thwe; Daniel A Ortiz; Alyssa L Wankewicz; J Patrik Hornak; Natalie Williams-Bouyer; Ping Ren
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

4.  Chromobacterium violaceum diarrhea.

Authors:  M Ballal; P Kini; D Rajeshwari; P G Shivananda
Journal:  Indian J Pediatr       Date:  2000-05       Impact factor: 1.967

5.  Two cases of Chromobacterium violaceum infection after injury in a subtropical region.

Authors:  J Lee; J S Kim; C H Nahm; J W Choi; J Kim; S H Pai; K H Moon; K Lee; Y Chong
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

6.  Chromobacterium violaceum septicemia.

Authors:  Shalini Shenoy; Shrikala Baliga; Godwin Wilson; Nutan Kamath
Journal:  Indian J Pediatr       Date:  2002-04       Impact factor: 1.967

Review 7.  Infections in patients with inherited defects in phagocytic function.

Authors:  Timothy Andrews; Kathleen E Sullivan
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

8.  A case of Chromobacterium infection after car accident in Korea.

Authors:  Myeong Hee Kim; Hee Joo Lee; Jin Tae Suh; Boo Soon Chang; Kyu Seok Cho
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

9.  Two siblings with fatal Chromobacterium violaceum sepsis linked to drinking water.

Authors:  Salman Mohammed Al Khalifa; Turki Al Khaldi; Manaf Mohammed Alqahtani; Ahmed Mohamed Al Ansari
Journal:  BMJ Case Rep       Date:  2015-08-30

10.  Necrotizing Pneumonia Caused by Chromobacterium violaceum: Report of a Rare Human Pathogen Causing Disease in an Immunodeficient Child.

Authors:  Alean A Frawley; Lauren Powell; John R McQuiston; Christopher A Gulvik; Rodolfo E Bégué
Journal:  Am J Trop Med Hyg       Date:  2018-04-19       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.